Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6192189rdf:typepubmed:Citationlld:pubmed
pubmed-article:6192189lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:6192189lifeskim:mentionsumls-concept:C0025919lld:lifeskim
pubmed-article:6192189lifeskim:mentionsumls-concept:C0021747lld:lifeskim
pubmed-article:6192189lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6192189lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:6192189lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:6192189pubmed:issue2lld:pubmed
pubmed-article:6192189pubmed:dateCreated1983-9-20lld:pubmed
pubmed-article:6192189pubmed:abstractTextThe cytostatic effect of murine interferon (IFN) on several BALB/c-derived B- and T-cell tumor cells was examined. After incubation for 1 h in vitro with 1000 U of IFN, followed by intraperitoneal inoculation, tumor formation was not decreased in the case of B cell tumors or Lyt-1+2- or Lyt-1+2+3+ T cells tumors. Under the same conditions, the onset of tumor formation for Lyt-2+3+ T-cell tumors was delayed and the final incidence decreased. When the effect of IFN on cell multiplication in vitro was examined, Lyt-2+3+ T-tumor cells were found to be more sensitive to the cytostatic effect of IFN than Lyt-1+2+3+ T-tumor cells. This shows that the sensitivity of lymphocyte-derived tumor cells to the cytostatic effect of IFN is influenced by the type of differentiation of the cells.lld:pubmed
pubmed-article:6192189pubmed:languageenglld:pubmed
pubmed-article:6192189pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6192189pubmed:citationSubsetIMlld:pubmed
pubmed-article:6192189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6192189pubmed:statusMEDLINElld:pubmed
pubmed-article:6192189pubmed:issn0197-8357lld:pubmed
pubmed-article:6192189pubmed:authorpubmed-author:PhillipsNNlld:pubmed
pubmed-article:6192189pubmed:authorpubmed-author:ParafAAlld:pubmed
pubmed-article:6192189pubmed:authorpubmed-author:De MaeyerEElld:pubmed
pubmed-article:6192189pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:6192189pubmed:authorpubmed-author:SimoninGGlld:pubmed
pubmed-article:6192189pubmed:issnTypePrintlld:pubmed
pubmed-article:6192189pubmed:volume3lld:pubmed
pubmed-article:6192189pubmed:ownerNLMlld:pubmed
pubmed-article:6192189pubmed:authorsCompleteYlld:pubmed
pubmed-article:6192189pubmed:pagination253-60lld:pubmed
pubmed-article:6192189pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6192189pubmed:meshHeadingpubmed-meshheading:6192189-...lld:pubmed
pubmed-article:6192189pubmed:meshHeadingpubmed-meshheading:6192189-...lld:pubmed
pubmed-article:6192189pubmed:meshHeadingpubmed-meshheading:6192189-...lld:pubmed
pubmed-article:6192189pubmed:meshHeadingpubmed-meshheading:6192189-...lld:pubmed
pubmed-article:6192189pubmed:meshHeadingpubmed-meshheading:6192189-...lld:pubmed
pubmed-article:6192189pubmed:meshHeadingpubmed-meshheading:6192189-...lld:pubmed
pubmed-article:6192189pubmed:meshHeadingpubmed-meshheading:6192189-...lld:pubmed
pubmed-article:6192189pubmed:meshHeadingpubmed-meshheading:6192189-...lld:pubmed
pubmed-article:6192189pubmed:year1983lld:pubmed
pubmed-article:6192189pubmed:articleTitleDifferential cytostatic effect of interferon on murine BALB/c B- and T-cell tumors.lld:pubmed
pubmed-article:6192189pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6192189pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed